Skip to main content
Clinical Trials/NCT03951064
NCT03951064TerminatedNot Applicable

Effect of Esophageal Pressure Measurement to Determine Optimal Positive End-expiratory Pressure Compared to Usual Care in Obese Patients Receiving Mechanical Ventilation

University of North Carolina, Chapel Hill2 sites in 1 country6 target enrollmentStarted: March 31, 2021Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Terminated
Enrollment
6
Locations
2
Primary Endpoint
Number of Ventilator-Free Days (VFD) by Day 28

Study Overview

Brief Summary

This is a research study to determine if identifying an optimal level of positive end-expiratory pressure (PEEP) targeted specifically to individualized patient characteristics will shorten the time on the ventilator.

Participants will have catheter placed through the nose into the esophagus to measure the pressure inside the chest. This catheter will remain until the patient is freed from the ventilator. Participants will be randomized to usual care or to have the level of PEEP determined by the esophageal balloon pressure readings. The total time spent on the ventilator will be recorded.

Detailed Description

Study Design:

Randomized-controlled clinical trial. Patients will be enrolled within 4 days of mechanical ventilation and randomized 1:1 to titration of PEEP based on esophageal balloon pressures or based on the "High PEEP" ARDSnet PEEP/fraction of inspired oxygen (FiO2) table. All patients will have esophageal balloons placed with baseline measurement of Ptp. Patients randomized to the intervention arm will then undergo titration of PEEP based on Ptp measurements to achieve "Optimal PEEP," defined as end expiratory Ptp of 0 to +2 cm water (H2O).

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Masking Description

Due to the obvious treatment differences between the two groups, blinding of treatment group will be impossible. However, the investigators will have one outcome assessor who will have access only to the data necessary to determine the primary outcome (Ventilator-Free Days at 28-days), and this assessor will be blinded to treatment group using built-in REDCap tools.

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Body mass index greater than or equal to 40
  • •Acute respiratory failure requiring mechanical ventilation

Exclusion Criteria

  • •Refusal to give consent by the subject or their legally authorized representative
  • •Abdominal compartment syndrome
  • •Chest tube for pneumothorax
  • •Having been on a ventilator for >4 days
  • •Suspicion of or known intracranial hypertension
  • •Anticipated extubation within 24 hours
  • •Chronic ventilator dependence
  • •Condition that precludes placement of an esophageal balloon (esophageal or nasopharyngeal pathology preventing insertion of the esophageal balloon catheter, severe thrombocytopenia or coagulopathy)
  • •Incarceration

Arms & Interventions

Optimal PEEP

Experimental

The waveforms of airway pressure (Paw), esophageal pressure (Pes), and transpulmonary pressure (Ptp) will be visualized on the ventilator. Ptp is obtained from Paw - Pes. PEEP will be increased on the ventilator to achieve a Ptp between 0 and +2 cm H2O (Optimal PEEP). Measurements will be obtained daily and adjustments to PEEP will occur daily. PEEP will be reduced below Optimal PEEP in the setting of hemodynamic compromise (requiring increasing vasoactive medications for blood pressure support).

Intervention: Esophageal balloon (Device)

Optimal PEEP

Experimental

The waveforms of airway pressure (Paw), esophageal pressure (Pes), and transpulmonary pressure (Ptp) will be visualized on the ventilator. Ptp is obtained from Paw - Pes. PEEP will be increased on the ventilator to achieve a Ptp between 0 and +2 cm H2O (Optimal PEEP). Measurements will be obtained daily and adjustments to PEEP will occur daily. PEEP will be reduced below Optimal PEEP in the setting of hemodynamic compromise (requiring increasing vasoactive medications for blood pressure support).

Intervention: Intervention Spontaneous Breathing Trial (SBT) and Extubation (Procedure)

Optimal PEEP

Experimental

The waveforms of airway pressure (Paw), esophageal pressure (Pes), and transpulmonary pressure (Ptp) will be visualized on the ventilator. Ptp is obtained from Paw - Pes. PEEP will be increased on the ventilator to achieve a Ptp between 0 and +2 cm H2O (Optimal PEEP). Measurements will be obtained daily and adjustments to PEEP will occur daily. PEEP will be reduced below Optimal PEEP in the setting of hemodynamic compromise (requiring increasing vasoactive medications for blood pressure support).

Intervention: Intervention Weaning after Tracheostomy (Procedure)

Acute Hypoxic Respiratory Distress Syndrome Network (ARDSNet) High PEEP

Active Comparator

PEEP in the control group will be determined by High PEEP ARDSnet PEEP/FiO2 table. Titration of PEEP will occur when clinically indicated by partial pressure of oxygen (PaO2) or oxygen saturation (SpO2), and FiO2. The investigators chose the High PEEP table based on the clinical suspicion that obese patients may require higher PEEP levels on average than non-obese patients to balance the additional pressure of their chest wall. In addition, EPVent2, a study of esophageal balloon PEEP titration in patients with ARDS utilized the High PEEP table. Patients with moderate and severe ARDS benefit from higher levels of PEEP.

Intervention: Esophageal balloon (Device)

Acute Hypoxic Respiratory Distress Syndrome Network (ARDSNet) High PEEP

Active Comparator

PEEP in the control group will be determined by High PEEP ARDSnet PEEP/FiO2 table. Titration of PEEP will occur when clinically indicated by partial pressure of oxygen (PaO2) or oxygen saturation (SpO2), and FiO2. The investigators chose the High PEEP table based on the clinical suspicion that obese patients may require higher PEEP levels on average than non-obese patients to balance the additional pressure of their chest wall. In addition, EPVent2, a study of esophageal balloon PEEP titration in patients with ARDS utilized the High PEEP table. Patients with moderate and severe ARDS benefit from higher levels of PEEP.

Intervention: Control Spontaneous Breathing Trial and Extubation (Procedure)

Acute Hypoxic Respiratory Distress Syndrome Network (ARDSNet) High PEEP

Active Comparator

PEEP in the control group will be determined by High PEEP ARDSnet PEEP/FiO2 table. Titration of PEEP will occur when clinically indicated by partial pressure of oxygen (PaO2) or oxygen saturation (SpO2), and FiO2. The investigators chose the High PEEP table based on the clinical suspicion that obese patients may require higher PEEP levels on average than non-obese patients to balance the additional pressure of their chest wall. In addition, EPVent2, a study of esophageal balloon PEEP titration in patients with ARDS utilized the High PEEP table. Patients with moderate and severe ARDS benefit from higher levels of PEEP.

Intervention: Control Weaning after Tracheostomy (Procedure)

Outcomes

Primary Outcomes

Number of Ventilator-Free Days (VFD) by Day 28

Time Frame: 28 days

The number of days a patient is alive and free from the ventilator up to day 28.

Secondary Outcomes

  • ICU Length of Stay(maximum duration of ICU stay, up to 46 days)
  • Number of Patients Receiving a Tracheostomy(during mechanical ventilation, up to 28 days)
  • Number of Participants Reintubated(72 hours after extubation)
  • Lowest Richmond Agitation and Sedation Scale(during mechanical ventilation, up to 28 days)
  • Hospital Length of Stay(maximum duration of hospital stay, up to 83 days)
  • Number of Patients Extubated Early(28 days)
  • Highest Richmond Agitation and Sedation Scale(during mechanical ventilation, up to 28 days)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials